{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:26Z","timestamp":1790727326876,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibrinogen-like protein 1 (FGL1) is a hepatokine that regulates hepcidin through antagonism of the bone morphogenetic protein (BMP) pathway. Although preclinical studies suggest a role for FGL1 in iron metabolism, its clinical behavior in human iron deficiency anemia (IDA) remains unclear. This study evaluates circulating FGL1 levels in IDA and examines its diagnostic performance and relationship with hematologic and biochemical markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study included 112 participants: healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      = 46), primary IDA (\n                      <jats:italic>n<\/jats:italic>\n                      = 46), and patients with IDA associated with chronic disease (IDA+CD) (\n                      <jats:italic>n<\/jats:italic>\n                      = 20). Hematologic indices, iron parameters, and serum FGL1 were measured. Group comparisons, correlation analysis, receiver operating characteristic (ROC) curves, and principal component analysis (PCA) were applied to assess diagnostic performance and multivariate biomarker structure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum FGL1 concentrations were significantly higher in primary IDA (median 411.2 ng\/ml) and IDA+CD (median 292.99 ng\/ml) than in healthy controls (median 212.49 ng\/ml;\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). Fibrinogen-like protein 1 did not differ significantly between IDA and IDA+CD (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.106). In primary IDA, FGL1 showed weak correlations with iron markers, whereas in IDA+CD it demonstrated moderate associations with hemoglobinization indices, particularly MCH (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.49). Receiver operating curve analysis showed excellent discrimination between healthy individuals and primary IDA (AUC 0.865) and good discrimination between healthy individuals and all disease groups combined (AUC 0.830). Fibrinogen-like protein 1 performed poorly in distinguishing primary IDA from IDA+CD (AUC 0.357). Principal component analysis showed that FGL1 clustered with classical markers of iron-restricted erythropoiesis along PC1, separating controls from both IDA groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Fibrinogen-like protein 1 is markedly elevated in iron deficiency and aligns with the broader biochemical signature of iron-restricted erythropoiesis. Its strong ability to distinguish healthy individuals from those with iron deficiency suggests diagnostic potential, particularly when ferritin interpretation is limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1767385","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:29:43Z","timestamp":1772774983000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of FGL1 as a hepatokine marker in iron deficiency"],"prefix":"10.3389","volume":"13","author":[{"given":"Muhammad","family":"Saboor","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Research Institute for Medical and Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad","family":"Abdul Rahim","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsah","family":"Nabi Dad","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer Mohamed","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mshael Mohammed","family":"Nasser","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat Mohsen","family":"Mansoor","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Health Sciences, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnane","family":"Guella","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Department of Nephrology, University Hospital Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Alkhayyal","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department, University Hospital Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e713","DOI":"10.1016\/S2352-3026(23)00160-6","article-title":"Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990\u20132021: findings from the global burden of disease study 2021","volume":"10","author":"Gardner","year":"2023","journal-title":"Lancet Haematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4274\/balkanmedj.galenos.2025.2024-11-24","article-title":"Neurodevelopmental impairments as long-term effects of iron deficiency in early childhood: A systematic review","volume":"42","author":"Theola","year":"2025","journal-title":"Balkan Med J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu16162808","article-title":"Impact of iron intake and reserves on cognitive function in young university students","author":"Dimas-Benedicto","year":"2024","journal-title":"Nutrients."},{"key":"B4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7754\/Clin.Lab.2020.200742","article-title":"Revisiting iron metabolism, iron homeostasis and iron deficiency anemia","volume":"67","author":"Saboor","year":"2021","journal-title":"Clin Lab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.3390\/jcm14134519","article-title":"Iron deficiency and iron deficiency anemia in chronic disease\u2014common, important, and treatable","volume":"14","author":"Moum","year":"2025","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5455\/mjhs.2021.03.012","article-title":"Hepcidin: structure, functions and role in hematological disorders","volume":"9","author":"Saboor","year":"2021","journal-title":"MJHS."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/blood-2018-03-841197","article-title":"Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6\/Hjv\/Smad signaling","volume":"132","author":"Fillebeen","year":"2018","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jhep.2012.06.015","article-title":"The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation","volume":"57","author":"D'alessio","year":"2012","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1182\/blood-2009-05-224808","article-title":"Down-regulation of Bmp\/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis","volume":"115","author":"Finberg","year":"2010","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1182\/blood-2006-06-027631","article-title":"Interleukin-6 induces hepcidin expression through STAT3","volume":"108","author":"Wrighting","year":"2006","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10275","DOI":"10.1074\/jbc.M116.770974","article-title":"Interleukin-1\u03b2 (IL-1\u03b2) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein \u03b4 (C\/EBP\u03b4) expression in hepatocytes","volume":"292","author":"Kanamori","year":"2017","journal-title":"J Biol Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"38702","DOI":"10.1038\/srep38702","article-title":"Regulation of hepcidin expression by inflammation-induced activin B","volume":"6","author":"Kanamori","year":"2016","journal-title":"Sci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3390\/biomedicines13092098","article-title":"Fetuin-A as a link between dyslipidemia and cardiovascular risk in type 2 diabetes: a metabolic insight for clinical practice","volume":"13","author":"Gavril","year":"2025","journal-title":"Biomedicines."},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12669\/pjms.36.2.1106","article-title":"Association of fetuin-A with dyslipidemia and insulin resistance in type-II diabetics of Pakistani population","volume":"36","author":"Fatima","year":"2020","journal-title":"Pak J Med Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1007\/s12033-023-00928-3","article-title":"FGL1 promotes tumor immune escape in stomach adenocarcinoma via the notch signaling pathway","volume":"66","author":"Zhou","year":"2024","journal-title":"Mol Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3000605221126874","DOI":"10.1177\/03000605221126874","article-title":"Fibrinogen like protein-1 knockdown suppresses the proliferation and metastasis of TU-686 cells and sensitizes laryngeal cancer to LAG-3 blockade","volume":"50","author":"Huang","year":"2022","journal-title":"J Int Med Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s12672-025-03337-x","article-title":"Effect of fibrinogen like protein 1 on cisplatin-resistance in laryngeal carcinoma through targeting integrin\u03b21 in vivo and in vitro","volume":"16","author":"Li","year":"2025","journal-title":"Discover Oncology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e20806","DOI":"10.1016\/j.heliyon.2023.e20806","article-title":"FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1182\/blood.2023022724","article-title":"The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling","volume":"143","author":"Sardo","year":"2024","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"12512025","DOI":"10.25259\/JKSUS_1251_2025","article-title":"Hepatokine FGL1 and hepcidin in anemia of chronic kidney disease: a cross sectional study","volume":"37","author":"Saboor","year":"2025","journal-title":"J King Saud Univ Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1182\/blood-2018-99-116109","article-title":"Hepatocyte iron content controls BMP6-dependent hepcidin regulation","volume":"132","author":"Altamura","year":"2018","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2478\/jomb-2018-0003","article-title":"Serum concentration of hepcidin as an indicator of iron reserves in children","volume":"37","author":"Culafi\u0107","year":"2018","journal-title":"J Med Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbrc.2007.11.069","article-title":"Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant","volume":"365","author":"Liu","year":"2008","journal-title":"Biochem Biophys Res Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00535-009-0159-y","article-title":"STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo","volume":"45","author":"Sakamori","year":"2010","journal-title":"J Gastroenterol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1767385\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:29:44Z","timestamp":1772774984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1767385\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":26,"alternative-id":["10.3389\/fnut.2026.1767385"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1767385","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"article-number":"1767385"}}